Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging
Abstract The widespread use of combinational antiretroviral therapies (cART) in developed countries has changed the course of Human Immunodeficiency Virus (HIV) infection from an almost universally fatal disease to a chronic infection for the majority of individuals. Although cART has reduced the se...
Guardado en:
Autores principales: | Alex M. Dickens, Seung Wan Yoo, Alfred C. Chin, Jiadi Xu, Tory P. Johnson, Amanda L. Trout, Kurt F. Hauser, Norman J. Haughey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9afe25e6dc247338322f014d0f67320 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
How to achieve Tat transport with alien TatA
por: René Steffen Hauer, et al.
Publicado: (2017) -
Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein
por: Hongping Jin, et al.
Publicado: (2016) -
Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells
por: Christophe Chopard, et al.
Publicado: (2018) -
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
por: Guillaume Mousseau, et al.
Publicado: (2015) -
Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A
por: Andrew P. Rice
Publicado: (2019)